| 1 | outer ear morphogenesis (GO:0042473) | 8.22579999 |
| 2 | polyamine biosynthetic process (GO:0006596) | 7.40892465 |
| 3 | artery development (GO:0060840) | 7.37411662 |
| 4 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 6.95043697 |
| 5 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 6.95043697 |
| 6 | facial nerve structural organization (GO:0021612) | 6.83645859 |
| 7 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 6.24701640 |
| 8 | arachidonic acid secretion (GO:0050482) | 5.88095791 |
| 9 | icosanoid secretion (GO:0032309) | 5.88095791 |
| 10 | multicellular organismal movement (GO:0050879) | 5.62188401 |
| 11 | musculoskeletal movement (GO:0050881) | 5.62188401 |
| 12 | negative regulation of sodium ion transport (GO:0010766) | 5.61725247 |
| 13 | synaptic transmission, dopaminergic (GO:0001963) | 5.37431290 |
| 14 | regulation of neurotransmitter uptake (GO:0051580) | 5.34082002 |
| 15 | low-density lipoprotein particle clearance (GO:0034383) | 5.25551799 |
| 16 | prepulse inhibition (GO:0060134) | 5.15660384 |
| 17 | cranial nerve structural organization (GO:0021604) | 5.15600742 |
| 18 | reflex (GO:0060004) | 5.04165611 |
| 19 | behavioral response to cocaine (GO:0048148) | 4.98754218 |
| 20 | regulation of proton transport (GO:0010155) | 4.98047852 |
| 21 | cellular biogenic amine biosynthetic process (GO:0042401) | 4.97881927 |
| 22 | response to histamine (GO:0034776) | 4.96442030 |
| 23 | cellular biogenic amine catabolic process (GO:0042402) | 4.90163853 |
| 24 | amine catabolic process (GO:0009310) | 4.90163853 |
| 25 | fatty acid derivative transport (GO:1901571) | 4.70351022 |
| 26 | icosanoid transport (GO:0071715) | 4.70351022 |
| 27 | amine biosynthetic process (GO:0009309) | 4.67508990 |
| 28 | mitochondrion morphogenesis (GO:0070584) | 4.62103474 |
| 29 | G-protein coupled receptor internalization (GO:0002031) | 4.57345487 |
| 30 | polyamine metabolic process (GO:0006595) | 4.51073738 |
| 31 | cardiovascular system development (GO:0072358) | 4.43030969 |
| 32 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 4.34953682 |
| 33 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 4.34626119 |
| 34 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.10500402 |
| 35 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.05615125 |
| 36 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.04569411 |
| 37 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.04569411 |
| 38 | striated muscle atrophy (GO:0014891) | 3.99671286 |
| 39 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.90992842 |
| 40 | positive regulation of renal sodium excretion (GO:0035815) | 3.77610355 |
| 41 | ubiquinone biosynthetic process (GO:0006744) | 3.72636004 |
| 42 | fatty acid homeostasis (GO:0055089) | 3.65900242 |
| 43 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.57422923 |
| 44 | natural killer cell mediated immunity (GO:0002228) | 3.57422923 |
| 45 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.52352296 |
| 46 | peristalsis (GO:0030432) | 3.44014010 |
| 47 | cochlea development (GO:0090102) | 3.43703597 |
| 48 | regulation of mitochondrial fission (GO:0090140) | 3.43593485 |
| 49 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.40692432 |
| 50 | skeletal muscle adaptation (GO:0043501) | 3.32708855 |
| 51 | behavioral response to nicotine (GO:0035095) | 3.28515577 |
| 52 | ubiquinone metabolic process (GO:0006743) | 3.26521247 |
| 53 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.25485742 |
| 54 | glycerol metabolic process (GO:0006071) | 3.24238827 |
| 55 | positive regulation of interleukin-17 production (GO:0032740) | 3.23549991 |
| 56 | muscle atrophy (GO:0014889) | 3.21656066 |
| 57 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.17711493 |
| 58 | response to amphetamine (GO:0001975) | 3.17499617 |
| 59 | cytokine production involved in immune response (GO:0002367) | 3.16291355 |
| 60 | skeletal muscle tissue regeneration (GO:0043403) | 3.12303457 |
| 61 | regulation of chronic inflammatory response (GO:0002676) | 3.10454932 |
| 62 | anatomical structure arrangement (GO:0048532) | 3.09417075 |
| 63 | negative regulation of mast cell activation (GO:0033004) | 3.08527292 |
| 64 | regulation of circadian sleep/wake cycle, sleep (GO:0045187) | 3.06061226 |
| 65 | regulation of circadian sleep/wake cycle (GO:0042749) | 3.06061226 |
| 66 | regulation of cellular senescence (GO:2000772) | 3.05931541 |
| 67 | positive regulation of protein homooligomerization (GO:0032464) | 3.05445982 |
| 68 | negative regulation of glial cell differentiation (GO:0045686) | 3.04195331 |
| 69 | piRNA metabolic process (GO:0034587) | 3.01741152 |
| 70 | quinone biosynthetic process (GO:1901663) | 3.01209508 |
| 71 | auditory receptor cell stereocilium organization (GO:0060088) | 3.00607289 |
| 72 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.99646776 |
| 73 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.99118482 |
| 74 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.96848506 |
| 75 | snRNA processing (GO:0016180) | 2.96368088 |
| 76 | production of molecular mediator of immune response (GO:0002440) | 2.94009710 |
| 77 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.92924592 |
| 78 | regulation of immunoglobulin secretion (GO:0051023) | 2.89995134 |
| 79 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.88541123 |
| 80 | circadian sleep/wake cycle process (GO:0022410) | 2.88514568 |
| 81 | spliceosomal complex assembly (GO:0000245) | 2.84324920 |
| 82 | mitotic cell cycle arrest (GO:0071850) | 2.82318815 |
| 83 | organic cation transport (GO:0015695) | 2.81633567 |
| 84 | alditol metabolic process (GO:0019400) | 2.77752464 |
| 85 | snRNA metabolic process (GO:0016073) | 2.76529786 |
| 86 | regulation of establishment of cell polarity (GO:2000114) | 2.74525263 |
| 87 | plasma lipoprotein particle clearance (GO:0034381) | 2.72793396 |
| 88 | mitochondrial RNA metabolic process (GO:0000959) | 2.68809990 |
| 89 | DNA deamination (GO:0045006) | 2.64726425 |
| 90 | regulation of interleukin-8 secretion (GO:2000482) | 2.62099526 |
| 91 | regulation of cellular respiration (GO:0043457) | 2.60814333 |
| 92 | proteasome assembly (GO:0043248) | 2.57431464 |
| 93 | regulation of phospholipase A2 activity (GO:0032429) | 2.57362059 |
| 94 | nephron tubule morphogenesis (GO:0072078) | 2.57003676 |
| 95 | nephron epithelium morphogenesis (GO:0072088) | 2.57003676 |
| 96 | iron ion import (GO:0097286) | 2.54786027 |
| 97 | grooming behavior (GO:0007625) | 2.52834460 |
| 98 | rRNA methylation (GO:0031167) | 2.52424033 |
| 99 | diacylglycerol metabolic process (GO:0046339) | 2.47343616 |
| 100 | regulation of renal sodium excretion (GO:0035813) | 2.44112896 |
NPM1P52 
